Market Closed -
Japan Exchange
11:30:00 02/05/2024 am IST
|
5-day change
|
1st Jan Change
|
1,020
JPY
|
-0.10%
|
|
+0.89%
|
-5.20%
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
23,692
|
14,088
|
13,888
|
17,226
|
9,889
|
11,199
|
Enterprise Value (EV)
1 |
25,859
|
14,232
|
15,842
|
23,015
|
14,595
|
16,421
|
P/E ratio
|
10.2
x
|
6.87
x
|
5.9
x
|
6.16
x
|
10.2
x
|
5.13
x
|
Yield
|
0.83%
|
1.79%
|
1.89%
|
1.6%
|
2.93%
|
2.71%
|
Capitalization / Revenue
|
0.1
x
|
0.05
x
|
0.05
x
|
0.06
x
|
0.04
x
|
0.04
x
|
EV / Revenue
|
0.11
x
|
0.06
x
|
0.06
x
|
0.08
x
|
0.05
x
|
0.05
x
|
EV / EBITDA
|
9.55
x
|
5.91
x
|
6.06
x
|
6.76
x
|
14.4
x
|
6.74
x
|
EV / FCF
|
5.99
x
|
5.96
x
|
-7.18
x
|
-4.55
x
|
11.9
x
|
265
x
|
FCF Yield
|
16.7%
|
16.8%
|
-13.9%
|
-22%
|
8.42%
|
0.38%
|
Price to Book
|
1.42
x
|
0.8
x
|
0.72
x
|
0.78
x
|
0.45
x
|
0.46
x
|
Nbr of stocks (in thousands)
|
14,011
|
13,990
|
13,792
|
13,792
|
13,792
|
13,792
|
Reference price
2 |
1,691
|
1,007
|
1,007
|
1,249
|
717.0
|
812.0
|
Announcement Date
|
29/06/18
|
20/06/19
|
29/06/20
|
25/06/21
|
29/06/22
|
28/06/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,39,531
|
2,58,481
|
2,77,260
|
2,86,173
|
2,78,162
|
3,04,445
|
EBITDA
1 |
2,707
|
2,407
|
2,616
|
3,406
|
1,013
|
2,435
|
EBIT
1 |
2,341
|
2,036
|
2,215
|
3,010
|
632
|
2,060
|
Operating Margin
|
0.98%
|
0.79%
|
0.8%
|
1.05%
|
0.23%
|
0.68%
|
Earnings before Tax (EBT)
1 |
3,228
|
3,050
|
3,331
|
4,123
|
1,532
|
3,181
|
Net income
1 |
2,313
|
2,050
|
2,366
|
2,796
|
972
|
2,182
|
Net margin
|
0.97%
|
0.79%
|
0.85%
|
0.98%
|
0.35%
|
0.72%
|
EPS
2 |
165.0
|
146.5
|
170.7
|
202.7
|
70.48
|
158.2
|
Free Cash Flow
1 |
4,314
|
2,387
|
-2,206
|
-5,062
|
1,230
|
61.88
|
FCF margin
|
1.8%
|
0.92%
|
-0.8%
|
-1.77%
|
0.44%
|
0.02%
|
FCF Conversion (EBITDA)
|
159.37%
|
99.16%
|
-
|
-
|
121.37%
|
2.54%
|
FCF Conversion (Net income)
|
186.52%
|
116.43%
|
-
|
-
|
126.49%
|
2.84%
|
Dividend per Share
2 |
14.00
|
18.00
|
19.00
|
20.00
|
21.00
|
22.00
|
Announcement Date
|
29/06/18
|
20/06/19
|
29/06/20
|
25/06/21
|
29/06/22
|
28/06/23
|
Fiscal Period: Marzo |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
1,40,256
|
1,45,892
|
1,41,870
|
68,404
|
73,714
|
1,52,281
|
77,323
|
81,416
|
1,67,240
|
85,429
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,005
|
2,227
|
588
|
37
|
241
|
716
|
545
|
246
|
1,181
|
225
|
Operating Margin
|
0.72%
|
1.53%
|
0.41%
|
0.05%
|
0.33%
|
0.47%
|
0.7%
|
0.3%
|
0.71%
|
0.26%
|
Earnings before Tax (EBT)
1 |
1,549
|
2,806
|
1,105
|
318
|
510
|
1,252
|
810
|
741
|
1,986
|
472
|
Net income
1 |
1,079
|
1,900
|
731
|
206
|
356
|
870
|
555
|
529
|
1,333
|
259
|
Net margin
|
0.77%
|
1.3%
|
0.52%
|
0.3%
|
0.48%
|
0.57%
|
0.72%
|
0.65%
|
0.8%
|
0.3%
|
EPS
2 |
77.50
|
137.8
|
53.06
|
14.92
|
25.86
|
63.12
|
40.27
|
38.40
|
96.69
|
18.79
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
06/11/19
|
11/11/20
|
11/11/21
|
09/02/22
|
10/08/22
|
10/11/22
|
09/02/23
|
09/08/23
|
09/11/23
|
08/02/24
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,167
|
144
|
1,954
|
5,789
|
4,706
|
5,222
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.8005
x
|
0.0598
x
|
0.7469
x
|
1.7
x
|
4.646
x
|
2.145
x
|
Free Cash Flow
1 |
4,314
|
2,387
|
-2,206
|
-5,062
|
1,230
|
61.9
|
ROE (net income / shareholders' equity)
|
15.2%
|
12.2%
|
13.2%
|
13.9%
|
4.16%
|
9.42%
|
ROA (Net income/ Total Assets)
|
1.61%
|
1.29%
|
1.37%
|
1.8%
|
0.36%
|
1.09%
|
Assets
1 |
1,43,371
|
1,58,718
|
1,72,776
|
1,55,351
|
2,72,193
|
2,00,404
|
Book Value Per Share
2 |
1,190
|
1,251
|
1,393
|
1,611
|
1,591
|
1,749
|
Cash Flow per Share
2 |
355.0
|
427.0
|
290.0
|
203.0
|
201.0
|
235.0
|
Capex
1 |
316
|
402
|
413
|
128
|
91
|
234
|
Capex / Sales
|
0.13%
|
0.16%
|
0.15%
|
0.04%
|
0.03%
|
0.08%
|
Announcement Date
|
29/06/18
|
20/06/19
|
29/06/20
|
25/06/21
|
29/06/22
|
28/06/23
|
|
1st Jan change
|
Capi.
|
---|
| -5.20% | 91.28M | | +19.98% | 43.48B | | +20.67% | 22.65B | | +14.56% | 14.73B | | +14.32% | 13.79B | | +44.72% | 12.04B | | -8.37% | 7.08B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +11.90% | 5.47B |
Generic Pharmaceuticals
|